Last reviewed · How we verify

Glycopyrronium 2.4 % Medicated Cloth

Pariser, Robert J., M.D. · Phase 2 active Small molecule

Glycopyrronium 2.4 % Medicated Cloth is a Small molecule drug developed by Pariser, Robert J., M.D.. It is currently in Phase 2 development. Also known as: Qbrexza.

At a glance

Generic nameGlycopyrronium 2.4 % Medicated Cloth
Also known asQbrexza
SponsorPariser, Robert J., M.D.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Glycopyrronium 2.4 % Medicated Cloth

What is Glycopyrronium 2.4 % Medicated Cloth?

Glycopyrronium 2.4 % Medicated Cloth is a Small molecule drug developed by Pariser, Robert J., M.D..

Who makes Glycopyrronium 2.4 % Medicated Cloth?

Glycopyrronium 2.4 % Medicated Cloth is developed by Pariser, Robert J., M.D. (see full Pariser, Robert J., M.D. pipeline at /company/pariser-robert-j-m-d).

Is Glycopyrronium 2.4 % Medicated Cloth also known as anything else?

Glycopyrronium 2.4 % Medicated Cloth is also known as Qbrexza.

What development phase is Glycopyrronium 2.4 % Medicated Cloth in?

Glycopyrronium 2.4 % Medicated Cloth is in Phase 2.

Related